Disposition of uric acid upon administration of ofloxacin alone and in combination with other anti-tuberculosis drugs

Indian Journal of Experimental Biology

Volumn 42, Issue 3, 2004, Pages 323-325

  Kumar, A K Hemanth ^a   Gurumurthy, Prema ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

Anti tuberculosis drugs; Ofloxacin; Uric acid disposition

Indexed keywords

DISEASE CONTROL; ORGANIC ACIDS; PULMONARY DISEASES; RANDOM PROCESSES; STATISTICAL METHODS;

URIC ACID;

DRUG THERAPY;

ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT; URIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; URINE;

ADULT; ANTITUBERCULAR AGENTS; CLINICAL TRIALS; HUMANS; ISONIAZID; MALE; OFLOXACIN; PYRAZINAMIDE; RIFAMPIN; URIC ACID;

EID: 1542320664     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kannapiran M, Krishnamurthy P V & Raghupati Sarma G, Uric acid disposition during intermittent chemotherapy of pulmonary tuberculosis with regimens containing pyrazinamide and rifampicin, Indian J Med Res, 82 (1985) 116.
2. Ellard G A & Haslam R M, Observations on the reduction of the renal elimination of urate in man caused by the administration of pyrazinamide, Tubercle, 57 (1976) 97.
3. Raghupati Sarma G, Acharyulu G S, Kannapiran M, Krishnamurthy P V, Prema Gurumurthy & Tripathy S P, Role of rifampicin in arthralgia induced by pyrazinamide, Tubercle, 64 (1983) 93.
4. Daniel Herbert, Paramasivan C N, Venkatesan P, Kubendran G, Prabhakar R & Mitchison D A, Evaluation of bactericidal action of ofloxacin and sulbactum-ampicillin alone and in combination with rifampicin and isoniazid on M. tuberculosis in vitro, Antimicrob Agents Chemother, 40 (1996) 2296.
5. Tuberculosis Research Centre, Shortening short course chemotherapy: A randomized clinical trial for treatment of smear positive pulmonary tuberculosis with regimens using ofloxacin in the intensive phase, Indian J Tubercul, 49 (2002) 27.
6. Henry R J, Sobel C & Kim J, A modified carbonate-phosphotungstate method for the determination of uric acid and comparison with the spectrophotometric uricase method. Am J Clin Pathol, 28 (1957) 645.
7. Larsen K, Creatinine assay by a reaction-kinetic principle, Clin Chim Acta, 41 (1972) 209.
8. Ellard G A, Absorption, metabolism and excretion of pyrazinamide in man, Tubercle, 50 (1969) 144.
9. Weiner I M & Tinker J P, Pharmacology of pyrazinamide: Metabolic and renal function studies related to the mechanism of drug-induced urate retention, J Pharmacol Exp Ther, 180 (1972) 411.
10. Yu T F, Berger L, Stone D J, Wolf J & Gutmann A B, Effect of pyrazinamide and pyrazinoic acid on urate clearance and other discrete renal functions, Proc Soc Exp Biol Med, 96 (1957) 264.
11. Fanelli G M & Weiner I M, Pyrazinoate excretion in the chimpanzee, Relation to urate disposition and the actions of uricosuric drugs, J Clin Invest, 52 (1973) 1946.
12. Gelber R H & Rees R J W, Dapsone metabolism in patients with dapsone-resistant leprosy, Am J Tropic Med Hyg, 24 (1975) 463.
13. Buffington G A, Dominguez J H, Piering W F, Herbert L A, Kauffman H M & Lemann J, Interaction of rifampicin and glucocorticoids: Adverse effect on renal allograft function, J Am Med Assoc, 236 (1976) 1958.
14. Raghupati Sarma G, Kailasam S, Nair N G K, Narayana A S L & Tripathy S P, Effect of prednisolone and rifampicin on isoniazid metabolism in slow and rapid inactivators of isoniazid, Antimicrob Agents Chemother, 18 (1980) 661.
15. Acocella G & Conti R, Interaction of rifampicin with other drugs, Tubercle, 61 (1980) 171.
16. Prema Gurumurthy, Nair N G K & Raghupati Sarma G, Methods for estimation of pyrazinamide and pyrazinoic acid in body fluids, Indian J Med Res, 71 (1980) 129.
17. Davis D J & Mckenzie B E, Toxicologic evaluation of ofloxacin, Am J Med, 87(6C) (1989) 43S.
18. Tack K J & Smith J A, The safety profile of ofloxacin, Am J Med, 87(6C) (1989) 78 S.